Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ

作者: Whitney Barham , Lianyi Chen , Oleg Tikhomirov , Halina Onishko , Linda Gleaves

DOI: 10.1186/S12885-015-1652-8

关键词:

摘要: Approximately 1 in 5 women diagnosed with breast cancer are considered to have situ disease, most often termed ductal carcinoma (DCIS). Though recognized as a risk factor for the development of more invasive cancer, it remains unclear what factors contribute DCIS development. It has been shown that inflammation contributes progression variety tumor types, and nuclear kappa B (NF-κB) is master-regulator inflammatory signaling. However, contributions NF-κB signaling initiation less well understood. Aberrant up-regulation activity, either systemically or locally within breast, could occur due commonly experienced stimuli such acute infection, obesity, psychological stress. In this study, we seek determine if activation mammary epithelium play role formation hyperplastic lesions. Our studies utilize doxycycline-inducible transgenic mouse model which constitutively active IKKβ expressed specifically epithelium. All previously published models modulation virgin gland constitutive models, transgene knock-out present throughout life animal. For first time, will induce at later time points after normal ducts formed, thus being able can promote pre-malignant changes We found even short pulse profound remodeling structures. Short-term created hyperproliferative, enlarged filled lumens. Increased expression markers was concurrent down-regulation hormone receptors epithelial differentiation. Furthermore, oncoprotein mucin 1, known be up-regulated human DCIS, over-expressed mislocalized activated tissue. These results indicate aberrant lead molecular morphological consistent earliest stages cancer. Thus, inhibition following initial signs growth represent an important opportunity prevention.

参考文章(50)
Pasquale Pellegrini, Alex Cordero, Marta Ines Gallego, William C. Dougall, Muñoz Purificación, Miguel Angel Pujana, Eva Gonzalez-Suarez, Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis Stem Cells. ,vol. 31, pp. 1954- 1965 ,(2013) , 10.1002/STEM.1454
Dong-sheng Cheng, Wei Han, Sabrina M. Chen, Taylor P. Sherrill, Melissa Chont, Gye-Young Park, James R. Sheller, Vasiliy V. Polosukhin, John W. Christman, Fiona E. Yull, Timothy S. Blackwell, Airway Epithelium Controls Lung Inflammation and Injury through the NF-κB Pathway Journal of Immunology. ,vol. 178, pp. 6504- 6513 ,(2007) , 10.4049/JIMMUNOL.178.10.6504
Lisa M. Coussens, Zena Werb, Inflammation and cancer Nature. ,vol. 420, pp. 860- 867 ,(2002) , 10.1038/NATURE01322
Eva Gonzalez-Suarez, Allison P. Jacob, Jon Jones, Robert Miller, Martine P. Roudier-Meyer, Ryan Erwert, Jan Pinkas, Dan Branstetter, William C. Dougall, RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis Nature. ,vol. 468, pp. 103- 107 ,(2010) , 10.1038/NATURE09495
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig, The natural history of ductal carcinoma in situ of the breast: a review Breast Cancer Research and Treatment. ,vol. 97, pp. 135- 144 ,(2006) , 10.1007/S10549-005-9101-Z
Toni Valković, Ksenija Lučin, Mira Krstulja, Renata Dobi-Babić, Nives Jonjić, Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathology Research and Practice. ,vol. 194, pp. 335- 340 ,(1998) , 10.1016/S0344-0338(98)80057-5
Ini-Isabée Witzel, Li Fang Koh, Neil D. Perkins, Regulation of cyclin D1 gene expression. Biochemical Society Transactions. ,vol. 38, pp. 217- 222 ,(2010) , 10.1042/BST0380217